Published in The Lancet, final overall survival results of the phase 3 TALAPRO-2 trial show that talazoparib plus enzalutamide significantly improves survival in patients with homologous recombination...
Read more
Un estudio multicéntrico liderado por el Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC) ha demostrado que el fármaco Paclitaxel, administrado mediante quimioterapia intraper...
Read more
It has been presented Upadacitinib as a new effective and safe therapeutic option for giant cell arteritis, an inflammatory disease that mainly affects the elderly and that until now had few treatment...
Read more
Palobiofarma is pleased to announce the successful completion of the industrial research project titled “Investigation of Dual Antagonist Compounds Targeting A2A and H3 Receptors for the Treatment o...
Read more
A team of rheumatology specialists from the Marqués de Valdecilla University Hospital (HUMV) and the Marqués de Valdecilla Health Research Institute (IDIVAL) has participated in a national multicent...
Read more
REBOOT trial, coordinated by the CNIC, shows that treatment with beta-blockers provides no benefit to patients who experience an uncomplicated heart attack that leaves the contractile function of the ...
Read more
Researchers from the Clinic-IDIBAPS lead an international study, published in The Lancet Respiratory Medicine, which demonstrates the importance of respiratory symptoms in prognosis and treatment resp...
Read more
The results of a phase 3 clinical trial show that orforglipron reduces body weight by an average of 11% and improves cardiovascular risk factors.
Read more
Estos hitos, más allá de marcar un notable avance terapéutico, representan la urgencia de mejorar el diagnóstico precoz, de definir claramente los criterios de acceso, de vigilancia de efectos adv...
Read more
A study published today in Nature Structural & Molecular Biology is the first time researchers have shown evidence that a single drug, already licensed for medical use, can stabilise nearly all mutate...
Read more
A University of Barcelona study published in the journal Pharmacological Research shows that pemafibrate and telmisartan, two drugs already approved for other conditions, effectively reduce fat accumu...
Read more
Both studies from the Digestive Service provide scientific evidence to transform the approach to these pathologies.
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Telum Therapeutics, a biotechnology company leveraging proprietary met...
